Cambridge Theranostics  
 
A New Treatment For Atherosclerosis
publications                                                                                                    

 
 


Petyaev, I. (2006). Lipid Oxidising Chlamydia Antibodies as a New Drug Target in the Treatment of Atherosclerosis in: Advances in Heart Disease-Proceedings of the 12th World Congress on Heart Disease-New Trends in Research and Treatment. Vanvouver Canada, July 16-19 2005. pp 277-283.

 

Advances in Heart Disease

 

New Products

   
 
             
 
 

© Copyright Cambridge Theranostics 2008. Registered in England and Wales No: 4314866; Registered office: 7 Hills Avenue, Cambridge CB1 7UY

class="bodyText">Cambridge Theranostics Ltd .